| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MAHON PAUL A | EVP & GENERAL COUNSEL | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 17 Mar 2026 | 0001231589 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | +8,895 | +24% | 45,739 | 15 Mar 2026 | Direct | F1 | ||
| transaction | UTHR | Common Stock | Options Exercise | +7,796 | +17% | 53,535 | 15 Mar 2026 | Direct | F1 | ||
| transaction | UTHR | Common Stock | Tax liability | -4,457 | -8.3% | $536.12* | 49,078 | 15 Mar 2026 | Direct | F2 | |
| transaction | UTHR | Common Stock | Tax liability | -3,906 | -8% | $536.12* | 45,172 | 15 Mar 2026 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Restricted Stock Units | Options Exercise | -8,895 | -100% | $0.000000* | 0 | 15 Mar 2026 | Common Stock | 8,895 | Direct | F1, F3 | ||
| transaction | UTHR | Restricted Stock Units | Options Exercise | -7,796 | -100% | $0.000000* | 0 | 15 Mar 2026 | Common Stock | 7,796 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. |
| F2 | Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units. |
| F3 | Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023. |